BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19363431)

  • 1. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.
    Dager SR; Corrigan NM; Richards TL; Posse S
    Top Magn Reson Imaging; 2008 Apr; 19(2):81-96. PubMed ID: 19363431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.
    Bustillo JR
    Dialogues Clin Neurosci; 2013 Sep; 15(3):329-37. PubMed ID: 24174904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy in psychiatry: basic principles and applications.
    Frangou S; Williams SC
    Br Med Bull; 1996 Jul; 52(3):474-85. PubMed ID: 8949251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.
    Schür RR; Draisma LW; Wijnen JP; Boks MP; Koevoets MG; Joëls M; Klomp DW; Kahn RS; Vinkers CH
    Hum Brain Mapp; 2016 Sep; 37(9):3337-52. PubMed ID: 27145016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.
    Spencer AE; Uchida M; Kenworthy T; Keary CJ; Biederman J
    J Clin Psychiatry; 2014 Nov; 75(11):1226-41. PubMed ID: 25271988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR spectroscopic studies of the brain in psychiatric disorders.
    Maddock RJ; Buonocore MH
    Curr Top Behav Neurosci; 2012; 11():199-251. PubMed ID: 22294088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise.
    Keshavan MS; Kapur S; Pettegrew JW
    Am J Psychiatry; 1991 Aug; 148(8):976-85. PubMed ID: 1853987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to change psychiatry's frame of reference for risk?
    Bartlett A
    BMJ; 2013 Mar; 346():f1544. PubMed ID: 23512448
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications.
    Panigrahy A; Nelson MD; Blüml S
    Pediatr Radiol; 2010 Jan; 40(1):3-30. PubMed ID: 19937238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine in psychiatry.
    Lass P; Sławek J
    Nucl Med Rev Cent East Eur; 2007; 10(2):116-24. PubMed ID: 18228217
    [No Abstract]   [Full Text] [Related]  

  • 15. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
    Dager SR; Steen RG
    Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing reductionism: reclaiming psychiatry.
    Sowers W
    Psychiatr Serv; 2005 Jun; 56(6):637. PubMed ID: 15939935
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional magnetic resonance in psychiatry.
    Sava S; Yurgelun-Todd DA
    Top Magn Reson Imaging; 2008 Apr; 19(2):71-9. PubMed ID: 19363430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Kim H; McGrath BM; Silverstone PH
    Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.
    Lee MR; Denic A; Hinton DJ; Mishra PK; Choi DS; Pirko I; Rodriguez M; Macura SI
    Bioanalysis; 2012 Jul; 4(14):1787-804. PubMed ID: 22877223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Viewpoint From Paris on the COVID-19 Pandemic: A Necessary Turn to Telepsychiatry.
    Corruble E
    J Clin Psychiatry; 2020 Mar; 81(3):. PubMed ID: 32237302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.